Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             84 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study Cohen, Stanley

3 p. 1159-1176
artikel
2 Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population Perrone, Valentina

3 p. 875-890
artikel
3 A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus Dörner, Thomas

3 p. 781-802
artikel
4 A Narrative Review of Acthar Gel for the Treatment of Myositis Chandra, Tanya

3 p. 523-537
artikel
5 An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren’s Syndrome Gairy, Kerry

3 p. 601-615
artikel
6 An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain Abraham, Lucy

3 p. 851-874
artikel
7 A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan Miyashiro, Masahiko

3 p. 615-634
artikel
8 A Threshold of Meaning for Work Disability Improvement in Psoriatic Arthritis Measured by the Work Productivity and Activity Impairment Questionnaire Tillett, William
2019
3 p. 379-391
artikel
9 Awareness and Expectations Surrounding Family Planning and Pregnancy Among Danish Patients with Chronic Inflammatory Disease of the Skin or Joints: Results from an Online Survey Johansen, Cæcilie B.

3 p. 1419-1433
artikel
10 Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials Salvarani, Carlo

3 p. 1435-1441
artikel
11 Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan Sullivan, Emma

3 p. 517-535
artikel
12 Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study Huang, Shirley P.

3 p. 551-562
artikel
13 Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study Weng, Chenghua

3 p. 635-648
artikel
14 Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison Huizinga, Thomas

3 p. 539-550
artikel
15 Clinical Presentation and Treatment of Juvenile Idiopathic Arthritis Combined with Lung Disease: A Narrative Review Gao, Feng-Qiao

3 p. 507-522
artikel
16 Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+ Harrold, Leslie R.

3 p. 575-587
artikel
17 Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial Gómez-Arango, Catalina

3 p. 1323-1339
artikel
18 Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis Nossent, Johannes C.
2019
3 p. 369-378
artikel
19 Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey Tillett, William

3 p. 617-637
artikel
20 Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications Merola, Joseph F.

3 p. 935-955
artikel
21 Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis Navarro-Compán, Victoria

3 p. 679-691
artikel
22 Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study Ye, Hua

3 p. 757-773
artikel
23 Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study Kivitz, Alan J.
2019
3 p. 393-407
artikel
24 Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits Rekaya, Naceur

3 p. 537-552
artikel
25 Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study Grazziotin, Luiza R.

3 p. 1303-1322
artikel
26 Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis Freites Nuñez, Dalifer

3 p. 1341-1354
artikel
27 Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study Doaré, Elise

3 p. 1241-1253
artikel
28 Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag Tsang, Yuen

3 p. 741-756
artikel
29 Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study Shi, Yu

3 p. 649-658
artikel
30 Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs Wells, Alvin F.
2019
3 p. 339-352
artikel
31 Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study Albert, John A.

3 p. 639-648
artikel
32 Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE Landewé, Robert

3 p. 581-599
artikel
33 Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey Rosenbaum, James T.
2019
3 p. 353-367
artikel
34 Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data Bykerk, Vivian P.

3 p. 693-706
artikel
35 Malignancy Risk of Immunoglobin G4-Related Disease: Evidence from a Large Cohort Multicenter Retrospective Study Liu, Yanying

3 p. 1207-1221
artikel
36 Mycophenolic Acid Exposure Optimization Based on Vitamin D Status in Children with Systemic Lupus Erythematosus: A Single-Center Retrospective Study Ye, Qiaofeng

3 p. 1143-1157
artikel
37 Novel Interventional Techniques for Chronic Pain with Minimally Invasive Arthrodesis of the Sacroiliac Joint: (INSITE, iFuse, Tricor, Rialto, and others) Kaye, Alan D.

3 p. 1061-1072
artikel
38 Nurse-Led Care for Stable Patients with Rheumatoid Arthritis: Quality of Care in Routine Practice Compared to the Traditional Rheumatologist-Led Model Lopatina, Elena

3 p. 1263-1285
artikel
39 Obesity and Psoriatic Arthritis: A Narrative Review Kumthekar, Anand

3 p. 447-456
artikel
40 Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia Freire de Carvalho, Jozélio

3 p. 1255-1261
artikel
41 Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study Hunter, Theresa

3 p. 1371-1382
artikel
42 Pain Pharmacotherapy in a Large Cohort of Patients with Osteoarthritis: A Real-World Data Analysis Fallach, Noga

3 p. 1129-1141
artikel
43 Patient Experience of Sjögren’s Disease and its Multifaceted Impact on Patients’ Lives Perella, Chiara

3 p. 601-614
artikel
44 Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey Birt, Julie A.

3 p. 1189-1205
artikel
45 Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey Richette, Pascal

3 p. 823-838
artikel
46 Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA Radawski, Christine
2019
3 p. 461-471
artikel
47 Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan Kishimoto, Mitsumasa

3 p. 1095-1111
artikel
48 Patient-Reported Outcome Measures in Takayasu Arteritis: A Systematic Review and Meta-Analysis Misra, Durga P.

3 p. 1073-1093
artikel
49 Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas Garrido-Cumbrera, Marco

3 p. 729-739
artikel
50 Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice Pappas, Dimitrios A.
2019
3 p. 421-433
artikel
51 Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers Spinella, Amelia

3 p. 891-905
artikel
52 Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis Giles, Jon T.

3 p. 1383-1391
artikel
53 Psoriatic Arthritis in Males and Females: Differences and Similarities Lubrano, Ennio

3 p. 589-599
artikel
54 Psoriatic Arthritis: What is Happening at the Joint? Belasco, Jennifer
2019
3 p. 305-315
artikel
55 Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies Cleanthous, Sophie

3 p. 1287-1301
artikel
56 Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data Kapoor, Sanjiv
2019
3 p. 451-459
artikel
57 Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib Perrone, Valentina

3 p. 657-665
artikel
58 Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review Ebbers, Hans C.
2019
3 p. 317-338
artikel
59 Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea Kim, Hyeongyeong

3 p. 1393-1404
artikel
60 Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial Michaud, Kaleb
2019
3 p. 409-419
artikel
61 Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence Coates, Laura C.

3 p. 803-821
artikel
62 Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials Eder, Lihi

3 p. 919-933
artikel
63 Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study Bingham, Clifton O.

3 p. 659-678
artikel
64 Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review Lwin, May N.

3 p. 457-471
artikel
65 Rheumatology Care in the Face of COVID-19 Lubrano, Ennio

3 p. 425-428
artikel
66 Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study Nash, Peter

3 p. 553-580
artikel
67 Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies Orbai, Ana-Maria

3 p. 1223-1240
artikel
68 Self-Reported Weather Sensitivity is Associated with Clinical Symptoms and Structural Abnormalities in Patients with Knee Osteoarthritis: A Cross-Sectional Study Xue, Yan

3 p. 1405-1417
artikel
69 Sjögren’s Syndrome and Viral Infections Liu, Zhiyong

3 p. 1051-1059
artikel
70 Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis Emery, Paul

3 p. 707-727
artikel
71 Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New Basta, Fabio

3 p. 433-446
artikel
72 The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis Lubrano, Ennio

3 p. 1443-1450
artikel
73 The Clinical Characteristics of Leukopenia in Patients with Systemic Lupus Erythematosus of Han Ethnicity in China: A Cross-Sectional Study Lu, Wentian

3 p. 1177-1188
artikel
74 The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital Wang, Yiyi

3 p. 775-784
artikel
75 Therapeutic Effects of Ba-Duan-Jin versus Pregabalin for Fibromyalgia Treatment: Protocol for a Randomized Controlled Trial Yang, Yang

3 p. 1451-1462
artikel
76 The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center AlEnzi, Fahidah

3 p. 649-656
artikel
77 TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study Salesi, Mansour

3 p. 1355-1370
artikel
78 Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts Huang, Hong

3 p. 907-917
artikel
79 Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis Mease, Philip
2019
3 p. 435-450
artikel
80 Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases Nossent, Johannes C.

3 p. 563-573
artikel
81 Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis Favalli, Ennio G.

3 p. 473-516
artikel
82 Unmet Needs in the Osteoarthritis Chronic Moderate to Severe Pain Management in Spain: A Real Word Data Study Castro-Domínguez, Francisco

3 p. 1113-1127
artikel
83 Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis Fleischmann, Roy M.

3 p. 839-850
artikel
84 Virtual Rheumatology During COVID-19: A Personal Perspective Dacre, Jane

3 p. 429-431
artikel
                             84 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland